Factor IX long-acting (OPKO Health)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor IX long-acting (OPKO Health)
Drug Alias NameFactor IX-CTPFIX-CTPMOD-9017
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProlor Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProlor BiotechOpko Health Inc
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A